Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00023244Phase 2Terminated
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
End-Stage Renal Disease
Principalinvestigator
NCT00240994Phase 2Completed
Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
ImmunosuppressionKidney Failure, ChronicKidney Transplantation
Studychair
NCT00307125Phase 2Completed
Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more
Principalinvestigator

Research Network

Collaboration Network

7 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anil Chandraker, MD

Brigham and Women's Hospital

Similar
4 trials

Shared therapeutic areas:

de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Failure, Chronic+3 more

Worked with same sponsors:

Clinical Trials in Organ TransplantationCooperative Clinical Trials in Pediatric Transplantation+1 more
Collaborated on 1 trial
Similarity Score64%

Mohamed H. Sayegh, MD

Brigham and Women's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more

Worked with same sponsors:

Clinical Trials in Organ TransplantationCooperative Clinical Trials in Pediatric Transplantation+1 more
Collaborated on 1 trial
Similarity Score44%

HS Kim, M.D.

Sinchon severance hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

SH Park, M.D.

St Vincent's Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

YJ Lee, M.D.

Korea University

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

CW Ko, M.D.

Kyungpook National University Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

SY Lee, M.D.

SMG-SNU Boramae Medical Center

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

JY Seo, M.D.

Eulji General Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00023244Phase 2PrincipalInvestigator

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

End-Stage Renal Disease
Terminated
NCT00240994Phase 2StudyChair

Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

ImmunosuppressionKidney Failure, ChronicKidney Transplantation
Completed
NCT00307125Phase 2PrincipalInvestigator

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more
Completed

All 3 trials loaded